Panuveitis: Clinical Trials

9 trials for Panuveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 9
Phase 25Completed 5

Follow Panuveitis: new trials by email Literature Review of Panuveitis trials Research Report on Panuveitis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis
8% Dexamethasone Sodium Phosphate - Visulex, 15% Dexamethasone Sodium Phosphate - Visulex, Prednisolone Acetate (1%) Eye Drops - Non-Infectious Anterior Uveitis
Phase 1 / Phase 2CompletedAciont Inc442014-10-012017-04-27
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis
Phase 1 / Phase 2CompletedClearside Biomedical, Inc.112013-02-012021-02-21
Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
Intravitreal Infliximab - Behçet's Disease, Uveitis
Phase 1 / Phase 2CompletedCairo University202013-01-012015-12-03
Anakinra for Behcet s Disease
Anakinra - Autoimmune Connective Tissue Disorder, Immune System Diseases
Phase 1 / Phase 2CompletedNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)62011-09-012017-05-12
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Interferon Gamma-1b - Anterior Uveitis, Uveitis
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)52011-06-012012-10-08
Sirolimus as Therapeutic Approach to Uveitis
Sirolimus (rapamycin) - Uveitis, Intermediate Uveitis
Phase 1CompletedJohns Hopkins University302009-07-012018-08-20
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Sirolimus - Anterior Uveitis
Phase 1CompletedNational Eye Institute (NEI)52009-04-012017-07-02
Prophylactic Anecortave Acetate in Patients With a Retisert Implant
anecortave acetate - Uveitis, Posterior, Glaucoma
Phase 1CompletedTexas Retina Associates122006-09-012012-06-05
The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
Chicken type II collagen - Arthritis, Juvenile Rheumatoid, Uveitis
Phase 1CompletedNational Eye Institute (NEI)131997-07-012008-03-04

Narrower conditions

Uveitis (9)  ·  Uveitis, Posterior (4)  ·  Uveitis, Anterior (3)  ·  Uveitis, Intermediate (3)  ·  Behcet Syndrome (2)  ·  Inflammation (2)  ·  Arthritis, Juvenile (1)  ·  Autoimmune Diseases (1)  ·  Choroidal Effusions (1)  ·  Giant Cell Arteritis (1)  ·  Glaucoma (1)  ·  Immune System Diseases (1)  ·  Iritis (1)  ·  Macular Edema (1)

Broader conditions

Eye Diseases (9)  ·  Uveal Diseases (9)  ·  Skin and Connective Tissue Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Immune System Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Uveitis, Anterior (3)  ·  Vascular Diseases (3)  ·  Vasculitis (3)  ·  Autoimmune Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hereditary Autoinflammatory Diseases (2)

Interventions

Sirolimus (2)  ·  Adrenal Cortex Hormones (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Ophthalmic Solutions (1)  ·  Triamcinolone (1)  ·  Triamcinolone Acetonide (1)  ·  anecortave acetate (1)  ·  interferon gamma-1b (1)  ·  prednisolone acetate (1)

Sponsors

National Eye Institute (NEI) (3)  ·  Aciont Inc (1)  ·  Cairo University (1)  ·  Clearside Biomedical, Inc. (1)  ·  Johns Hopkins University (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)  ·  Texas Retina Associates (1)

Countries

United States (8)

Top investigators

David G Callanan, MD (1)  ·  Hatice Nida Sen, MD, MHSc (1)  ·  Mahmoud Soliman, MD PhD (1)  ·  Peter C Grayson, M.D. (1)  ·  Quan D Nguyen, MD, MSc (1)  ·  Thomas Ciulla, MD (1)  ·  William I Higuchi, PhD (1)

Results publications

PMID 22465364, PMID 25918559, PMID 27980877, PMID 28335798

NIH funding

R44EY014772 (1)